As of November 2024 Adaptive Biotechnologies has a market cap of A$1.05 Billion. This makes Adaptive Biotechnologies the world's 6162th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 24th, 2024 the market cap of Adaptive Biotechnologies was reported to be: